Related Experiment Video
Updated: Mar 19, 2026
09:44
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
10.7K
Quantitative 3D Determination of Radiosensitization by Bismuth-Based Nanoparticles.
Journal of Biomedical Nanotechnology
|June 10, 2016
Summary
Bismuth-based nanoparticles show promise in enhancing radiation therapy doses, potentially outperforming gold nanoparticles. This study quantifies their dose enhancement effects using novel 3D phantoms and X-ray beams.
Area of Science:
- Medical Physics
- Nanotechnology
- Radiotherapy
Background:
- Nanoparticle-induced dose enhancement improves radiotherapy efficacy.
- Gold nanoparticles (AuNPs) have been studied, but other high atomic number (Z) nanomaterials require investigation.
Purpose of the Study:
- To quantify dose enhancement of bismuth oxide (Bi2O3-NPs) and bismuth sulfide (Bi2S3-NPs).
- To compare the efficacy of bismuth-based nanoparticles against AuNPs for radiation dose enhancement.
Main Methods:
- Experimental validation using phantom cuvettes with and without nanoparticles.
- 3D phantoms to assess spatial dose deposition distribution.
- Irradiation with kilovoltage and megavoltage X-ray beams; measurement via spectrophotometer and optical CT scanner.
Main Results:
- Bismuth oxide nanoparticles (50 nm) showed a dose enhancement factor (DEF) of 1.90 vs. 1.77 for AuNPs at 100 kV.
- Bismuth sulfide nanoparticles (5 nm) showed a DEF of 1.38 vs. 1.51 for AuNPs at 150 kV.
- Dose enhancement was significantly lower (<15%) for 6 MV energy compared to kilovoltage energy.
Conclusions:
- Bismuth-based nanoparticles effectively enhance radiation dose.
- Bismuth nanoparticles present a potential alternative to AuNPs in radiotherapy, with varying efficacy based on material and energy.
